Ryman Healthcare Dividends and Buybacks
Dividend criteria checks 0/6
Ryman Healthcare does not currently pay a dividend.
Key information
0%
Dividend yield
-0.1%
Buyback Yield
| Total Shareholder Yield | -0.1% |
| Future Dividend Yield | 1.2% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | NZ$0.224 |
| Payout ratio | 0% |
Recent dividend and buyback updates
Recent updates
Is Ryman Healthcare Limited (NZSE:RYM) Trading At A 42% Discount?
Nov 25
Is Ryman Healthcare (NZSE:RYM) Weighed On By Its Debt Load?
Aug 16Are Investors Undervaluing Ryman Healthcare Limited (NZSE:RYM) By 47%?
Jul 12Ryman Healthcare's (NZSE:RYM) Soft Earnings Don't Show The Whole Picture
Jun 05Little Excitement Around Ryman Healthcare Limited's (NZSE:RYM) Earnings
May 21Returns On Capital At Ryman Healthcare (NZSE:RYM) Paint A Concerning Picture
Apr 24Ryman Healthcare Limited's (NZSE:RYM) P/E Is On The Mark
Feb 08Here's Why Ryman Healthcare (NZSE:RYM) Has A Meaningful Debt Burden
Jan 07Capital Allocation Trends At Ryman Healthcare (NZSE:RYM) Aren't Ideal
Dec 20What Is Ryman Healthcare Limited's (NZSE:RYM) Share Price Doing?
Sep 11Ryman Healthcare (NZSE:RYM) Has Debt But No Earnings; Should You Worry?
Jul 04Ryman Healthcare Limited (NZSE:RYM) Shares Could Be 24% Below Their Intrinsic Value Estimate
May 30Should You Think About Buying Ryman Healthcare Limited (NZSE:RYM) Now?
Aug 26When Should You Buy Ryman Healthcare Limited (NZSE:RYM)?
May 04What Is Ryman Healthcare Limited's (NZSE:RYM) Share Price Doing?
Jan 08Investors Could Be Concerned With Ryman Healthcare's (NZSE:RYM) Returns On Capital
Oct 14Is It Too Late To Consider Buying Ryman Healthcare Limited (NZSE:RYM)?
Sep 14Is Ryman Healthcare (NZSE:RYM) Using Too Much Debt?
Aug 04Should You Think About Buying Ryman Healthcare Limited (NZSE:RYM) Now?
May 22Is Ryman Healthcare Limited (NZSE:RYM) A Good Fit For Your Dividend Portfolio?
Apr 17Should You Review Recent Insider Transactions At Ryman Healthcare Limited (NZSE:RYM)?
Mar 20Our Take On The Returns On Capital At Ryman Healthcare (NZSE:RYM)
Mar 07Do Institutions Own Ryman Healthcare Limited (NZSE:RYM) Shares?
Feb 23Returns On Capital At Ryman Healthcare (NZSE:RYM) Paint An Interesting Picture
Nov 23Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if RYM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if RYM's dividend payments have been increasing.
Dividend Yield vs Market
| Ryman Healthcare Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (RYM) | 0% |
| Market Bottom 25% (NZ) | 3.5% |
| Market Top 25% (NZ) | 6.3% |
| Industry Average (Healthcare) | 2.9% |
| Analyst forecast (RYM) (up to 3 years) | 1.2% |
Notable Dividend: Unable to evaluate RYM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate RYM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: RYM is not paying a notable dividend for the NZ market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as RYM has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 10:11 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ryman Healthcare Limited is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andrew Steele | Credit Suisse |
| Stephen Ridgewell | Deutsche Bank |
| Aaron Ibbotson | Forsyth Barr Group Ltd. |